The decline in activity of CYP enzymes in enterocytes and hepatocytes is more pronounced as the severity of cirrhosis increases,95 explaining the different magnitude of effects simulated on imatinib PK in patients with Child‐Pugh B/C cirrhosis and Child‐Pugh A cirrhosis. This evidence concerns the gene PPIG and Cirrhosis.